Review
doi: 10.1016/j.cmet.2006.01.004.The biology of incretin hormones
Affiliations
- PMID:16517403
- DOI: 10.1016/j.cmet.2006.01.004
Item in Clipboard
Review
The biology of incretin hormones
Daniel J Drucker. Cell Metab.2006 Mar.
Free article Display options
Format
Display options
Format
Abstract
Gut peptides, exemplified by glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are secreted in a nutrient-dependent manner and stimulate glucose-dependent insulin secretion. Both GIP and GLP-1 also promote beta cell proliferation and inhibit apoptosis, leading to expansion of beta cell mass. GLP-1, but not GIP, controls glycemia via additional actions on glucose sensors, inhibition of gastric emptying, food intake and glucagon secretion. Furthermore, GLP-1, unlike GIP, potently stimulates insulin secretion and reduces blood glucose in human subjects with type 2 diabetes. This article summarizes current concepts of incretin action and highlights the potential therapeutic utility of GLP-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors for the treatment of type 2 diabetes.
Similar articles
- The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.Edholm T, Cejvan K, Abdel-Halim SM, Efendic S, Schmidt PT, Hellström PM.Edholm T, et al.Neurogastroenterol Motil. 2009 Mar;21(3):313-21. doi: 10.1111/j.1365-2982.2008.01229.x. Epub 2008 Dec 18.Neurogastroenterol Motil. 2009.PMID:19126188
- What do we know about the secretion and degradation of incretin hormones?Deacon CF.Deacon CF.Regul Pept. 2005 Jun 15;128(2):117-24. doi: 10.1016/j.regpep.2004.06.007.Regul Pept. 2005.PMID:15780431Review.
- [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].Diamant M, Bunck MC, Heine RJ.Diamant M, et al.Ned Tijdschr Geneeskd. 2004 Sep 25;148(39):1912-7.Ned Tijdschr Geneeskd. 2004.PMID:15495988Review.Dutch.
- Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus.Freeman JS.Freeman JS.Cleve Clin J Med. 2009 Dec;76 Suppl 5:S12-9. doi: 10.3949/ccjm.76.s5.03.Cleve Clin J Med. 2009.PMID:19952298Review.
- A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.Green BD, Gault VA, O'Harte FP, Flatt PR.Green BD, et al.Diabetes Obes Metab. 2005 Sep;7(5):595-604. doi: 10.1111/j.1463-1326.2004.00455.x.Diabetes Obes Metab. 2005.PMID:16050953
Cited by
- GLP-1 Agonism for Kidney Transplant Recipients: A Narrative Review of Current Evidence and Future Directions Across the Research Spectrum.Riehl-Tonn VJ, Medak KD, Rampersad C, MacPhee A, Harrison TG.Riehl-Tonn VJ, et al.Can J Kidney Health Dis. 2024 Oct 31;11:20543581241290317. doi: 10.1177/20543581241290317. eCollection 2024.Can J Kidney Health Dis. 2024.PMID:39492845Free PMC article.Review.
- Effects of glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in high-risk type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Chen X, Zhang X, Xiang X, Fang X, Feng S.Chen X, et al.Diabetol Metab Syndr. 2024 Oct 26;16(1):251. doi: 10.1186/s13098-024-01497-4.Diabetol Metab Syndr. 2024.PMID:39456002Free PMC article.
- Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.Guo X, Li H, Xu H, Halim V, Thomas LN, Woo SL, Huo Y, Chen YE, Sturino JM, Wu C.Guo X, et al.J Nutr Biochem. 2013 May;24(5):770-5. doi: 10.1016/j.jnutbio.2012.04.007. Epub 2012 Jul 26.J Nutr Biochem. 2013.PMID:22841546Free PMC article.
- Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin.Liu H, Hu Y, Li FF, Liu BL, Su XF, Ma JH.Liu H, et al.Diabetes Ther. 2016 Dec;7(4):743-753. doi: 10.1007/s13300-016-0200-0. Epub 2016 Oct 12.Diabetes Ther. 2016.PMID:27734321Free PMC article.
- The acute impact of ingestion of sourdough and whole-grain breads on blood glucose, insulin, and incretins in overweight and obese men.Mofidi A, Ferraro ZM, Stewart KA, Tulk HM, Robinson LE, Duncan AM, Graham TE.Mofidi A, et al.J Nutr Metab. 2012;2012:184710. doi: 10.1155/2012/184710. Epub 2012 Feb 28.J Nutr Metab. 2012.PMID:22474577Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous